Oncogenic BRAF-Mediated Melanoma Cell Invasion
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Melanoma patients with oncogenic BRAF(V600E) mutation have poor prognoses. While the role of BRAF(V600E) in tumorigenesis is well established, its involvement in metastasis that is clinically observed in melanoma patients remains a topic of debate. Here, we show that BRAF(V600E) melanoma cells have extensive invasion activity as assayed by the generation of F-actin and cortactin foci that mediate membrane protrusion, and degradation of the extracellular matrix (ECM). Inhibition of BRAF(V600E) blocks melanoma cell invasion. In a BRAF(V600E)-driven murine melanoma model or in patients' tumor biopsies, cortactin foci decrease upon inhibitor treatment. In addition, genome-wide expression analysis shows that a number of invadopodia-related genes are downregulated after BRAF(V600E) inhibition. Mechanistically, BRAF(V600E) induces phosphorylation of cortactin and the exocyst subunit Exo70 through ERK, which regulates actin dynamics and matrix metalloprotease secretion, respectively. Our results provide support for the role of BRAF(V600E) in metastasis and suggest that inhibiting invasion is a potential therapeutic strategy against melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 4×
“We find that short-term expression of BRAFV600E is sufficient to promote invasion, whereas long-term expression of BRAFV600E induces growth arrest, which is reminiscent of the oncogene-induced senescence (OIS) documented previously (Damsky et al., 2015; Dhomen et al., 2009; Michaloglou et al., 2005; Vredeveld et al.,…”
BackgroundResultInfluentialVan Cutsem, E., Köhne, C.-H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5091 · Cited by 1,882 · cited 3×
“…compared to BRAF wild-type melanoma, which is similar to what has been observed in other types of cancer (Cho et al., 2006; Davies et al., 2002; Long et al., 2011; Menzies et al., 2012; Nikiforova et al., 2003; Roth et al., 2010; Ugurel et al., 2007; Van Cutsem et al., 2011; Yokota et al., 2011).”
ResultRAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikakos, P. I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M. T., et al. (2011) · Nature · doi:10.1038/nature10662 · Cited by 1,454 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript negative control. siRNA targeting both wild-type BRAF and BRAFV600E (“siBRAF”) (Poulikakos et al., 2011) effectively reduced the expression of BRAF in all four melanoma cell lines (Supplemental Figure 1A and 1B).”
BackgroundBrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · cited 4×
“We find that short-term expression of BRAFV600E is sufficient to promote invasion, whereas long-term expression of BRAFV600E induces growth arrest, which is reminiscent of the oncogene-induced senescence (OIS) documented previously (Damsky et al., 2015; Dhomen et al., 2009; Michaloglou et al., 2005; Vredeveld et al.,…”
BackgroundResultInfluentialmTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation
Damsky, W., Micevic, G., Meeth, K., Muthusamy, V., Curley, D. P., Santhanakrishnan, M., Erdelyi, I., Platt, J. T., Huang, L., Theodosakis, N., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.014 · Cited by 142 · cited 4×
“…(data not shown), similar to previous reports that BRAFV600E induces cell growth arrest and senescence as a cellular response to oncogenic BRAF (Damsky et al., 2015; Damsky et al., 2011; Dankort et al., 2009; Dhomen et al., 2009; Michaloglou et al., 2005; Vredeveld et al., 2012; Wajapeyee et…”
BackgroundResultInfluential
Cited by
Mutational drivers of cancer cell migration and invasion
Novikov, N. M., Zolotaryova, S. Y., Gautreau, A. M., & Denisov, E. V. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01149-0 · Cited by 302
Cryo-EM structure of the exocyst complex
Mei, K., Li, Y., Wang, S., Shao, G., Wang, J., Ding, Y., Luo, G., Yue, P., Liu, J.-J., Wang, X., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0016-2 · Cited by 156
Self-citationMelanin Transfer in the Epidermis: The Pursuit of Skin Pigmentation Control Mechanisms
Moreiras, H., Seabra, M. C., & Barral, D. C. (2021) · doi:10.20944/preprints202104.0441.v1 · Cited by 147
Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter
Redmer, T. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0854-5 · Cited by 67
“The stable expression of CD271 enhanced the migratory phenotype even of A375 cells [88], which is intrinsically mediated by oncogenic BRAF via the phosphorylation of cortactin and the exocyst subunit Exo70 [89] and through the ERK1/2-mediated downregulation of the cGMP-specific phosphodiesterase PDE5A [90].”
BackgroundULK1 phosphorylates Exo70 to suppress breast cancer metastasis
Mao, L., Zhan, Y.-Y., Wu, B., Yu, Q., Xu, L., Hong, X., Zhong, L., Mi, P., Xiao, L., Wang, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13923-7 · Cited by 58
Self-citation
Metadata
- Authors
- Lu, H., Liu, S., Zhang, G., Kwong, L. N., Zhu, Y., Miller, J. P., Hu, Y., Zhong, W., Zeng, J., Wu, L., Krepler, C., Sproesser, K., Xiao, M., Xu, W., Karakousis, G. C., Schuchter, L. M., Field, J., Zhang, P. J., Herlyn, M., Xu, X., & Guo, W.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 15
- Issue
- 9
- Pages
- 2012-2024
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2396385691
- Cited by
- 61
- References
- 6
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.